Tranexamic Acid Market: US$ 89.81 Million to US$ 116.28 Million by 2034, 2.91% CAGR
Heavy bleeding is among the oldest problems in medicine, and a low-cost molecule first developed in the 1960s still sits at the centre of how clinicians manage it. Looking ahead, the Tranexamic Acid Market is projected to reach US$ 116.28 million by 2034, up from US$ 89.81 million in 2025. That trajectory equates to a … Read more